
# Title 42 - Public Health
## Chapter I - Public Health Service, Department of Health and Human Services
### Subchapter A - General Provisions
#### PART 11 - CLINICAL TRIALS REGISTRATION AND RESULTS INFORMATION SUBMISSION
##### Subpart C - Results Information Submission
###### ยง 11.42 For which applicable clinical trials must clinical trial results information be submitted?
####### Applicable clinical trials for which the studied product is approved, licensed, or cleared by FDA.

(a)Unless a waiver of the requirement to submit clinical trial results information is granted in accordance with ยง 11.54, clinical trial results information must be submitted for any applicable clinical trial for which the studied product is approved, licensed, or cleared by FDA for which submission of clinical trial registration information is required in accordance with the following:

(1) If the primary completion date is before January 18, 2017, the responsible party must submit the clinical trial results information specified in sections 402(j)(3)(C) and 402(j)(3)(I) of the Public Health Service Act (42 U.S.C. 282(j)(3)(C) and 42 U.S.C. 282(j)(3)(I)); or

(2) If the primary completion date is on or after January 18, 2017, the responsible party must submit the clinical trial results information specified in ยง 11.48.
